SERIES A/SERIES B] COMMON STOCK PURCHASE WARRANT CHECKPOINT THERAPEUTICS, INC.Checkpoint Therapeutics, Inc. • October 3rd, 2023 • Pharmaceutical preparations • New York
THIS [SERIES A/SERIES B] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) and on or prior to 5:00 p.m. (New York City time) on [______________] 1 2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Checkpoint Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT CHECKPOINT THERAPEUTICS, INC.Checkpoint Therapeutics, Inc. • October 3rd, 2023 • Pharmaceutical preparations • New York
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) and on or prior to 5:00 p.m. (New York City time) on October 4, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Checkpoint Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter, dated as of September 29, 2023, by and between the Company and H.C. Wainwright & Co., LLC.
